Reduction or withdrawal of etanercept after remission with etanerceptin patients with rheumatoid arthritis patients.
Not Applicable
- Conditions
- rheumatoid arthritis
- Registration Number
- JPRN-UMIN000012613
- Lead Sponsor
- Dept. of orthopedic surgery, Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
patients withoout remission stage(DAS28 under 2.6) after etanercept50mg/wk or25mg twice/wk
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method activity score of rheumatoid arthritis: DAS(Disease Activity Score),swollen joint count, tender joint cont, ESR, patient VAS, CRP
- Secondary Outcome Measures
Name Time Method